PMC:13921 / 3363-4049 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/13921","sourcedb":"PMC","sourceid":"13921","source_url":"http://www.ncbi.nlm.nih.gov/pmc/13921","text":"Results:\nSerial plasma samples from 1006 patients with breast cancer revealed the following: (i) no correlation of p53 autoantibody status with disease status at the time of sample collection (Table 1), or with menopausal status at time of primary diagnosis of breast cancer (Table 2); (ii) 155 out of 1006 (15%) of patients were positive for p53 autoantibodies, and these patients tended to have a persistent autoantibody status throughout follow up, irrespective of disease behaviour; and (iii) where a negative autoantibody status was found at primary diagnosis of breast cancer, this negative status persisted throughout follow up, irrespective of later disease behaviour (Table 3).","divisions":[{"label":"Title","span":{"begin":0,"end":8}}],"tracks":[]}